Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple Therapy (Csa-LES) in Lupus Nephritis
NCT01299922Phase 3Withdrawn
- Sponsor
- Hospital Universitario Fundación Alcorcón
- Start
- Feb 2011
- Primary completion
- Mar 2014
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyclosporine in lupus nephritis (LN), sponsored by Hospital Universitario Fundación Alcorcón. Planned start Feb 2011; status: withdrawn.
02
Drugs
cyclosporine
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT01299922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01299922.